Lifecore Biomedical, Inc. \De\ (LFCR) Change in Account Payables (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Change in Account Payables history runs 16 years deep, the most recent figure standing at $1.0 million for Q2 2025.

• In Q2 2025, Change in Account Payables rose 150.7% year-over-year to $1.0 million; the TTM figure through May 2025 stood at -$1.7 million (up 74.99% YoY), while the FY2025 annual figure was -$1.7 million, up 74.99% from the prior year.
• Change in Account Payables for Q2 2025 stood at $1.0 million, up from -$3.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $13.7 million in Q4 2021, with the low at -$12.4 million in Q2 2021.
• The 5-year median for Change in Account Payables is -$367500.0 (2023), against an average of $28555.6.
• The sharpest annual moves came in 2023 and 2024: Change in Account Payables surged 212.34% in 2023, then tumbled 4708.47% in 2024.
• Lifecore Biomedical, Inc. \De\'s Change in Account Payables stood at $13.7 million in 2021, then decreased by 18.67% to $11.1 million in 2022, then slumped by 100.53% to -$59000.0 in 2023, then sank by 4708.47% to -$2.8 million in 2024, then soared by 136.8% to $1.0 million in 2025.
• Business Quant data shows LFCR's Change in Account Payables at $1.0 million in Q2 2025, -$3.5 million in Q1 2025, and -$2.8 million in Q4 2024.